Liver disease: Conscious uncoupling in NASH
Nature Reviews Drug Discovery 16, 238 (2017).
doi:10.1038/nrd.2017.60
Author: M. Teresa Villanueva
Non-alcoholic steatohepatitis (NASH) — an inflammatory disease that can progress to cirrhosis and end-stage liver disease — is becoming increasingly common, and there are no approved pharmacological therapies. Wang et al. have now identified that CASP8 and FADD-like apoptosis regulator (CFLAR) can suppress steatohepatitis
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: M. Teresa Villanueva Tags: Research Highlight Source Type: research
More News: Alcoholism | Cirrhosis | Drugs & Pharmacology | Liver | Liver Disease | Urology & Nephrology